Evidence map›Paper›PMID 38395877›Full record

ArticleBMC public health2024

High prevalence of zero-dose children in underserved and special setting populations in Ethiopia using a generalize estimating equation and concentration index analysis.

Gashaw Andargie Biks, Fisseha Shiferie, Dawit Abraham Tsegaye, Wondwossen Asefa, Legese Alemayehu, Tamiru Wondie, Meseret Zelalem, Yohannes Lakew, Kidist Belete, Samson Gebremedhin

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
26.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Gashaw Andargie BiksProject HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia. Gandargie@projecthope.org.
Fisseha ShiferieProject HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia.
Dawit Abraham TsegayeProject HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia.
Wondwossen AsefaProject HOPE Headquarter, Washington, D.C, USA.
Legese AlemayehuProject HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia.
Tamiru WondieProject HOPE, Ethiopia Country Office, Addis Ababa, Ethiopia.
Meseret ZelalemMaternal and Child Health, Minister of Health, Addis Ababa, Ethiopia.
Yohannes LakewMaternal and Child Health, Minister of Health, Addis Ababa, Ethiopia.
Kidist BeleteUSAID, Addis Ababa, Ethiopia.
Samson GebremedhinSchool of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Federal Ministry of Health · ETAddis Ababa University · ETInternational Trachoma Initiative · ETProject HOPE · US

Funding

Bill and Melinda Gates Foundation NV 018567
6 · The paper itself

Abstract

backgroundGlobally, according to the World Health Organization (WHO) 2023 report, more than 14.3 million children in low- and middle-income countries, primarily in Africa and South-East Asia, are not receiving any vaccinations. Ethiopia is one of the top ten countries contributing to the global number of zero-dose children.

objectiveTo estimate the prevalence of zero-dose children and associated factors in underserved populations of Ethiopia.

methodsA cross-sectional vaccine coverage survey was conducted in June 2022. The study participants were mothers of children aged 12-35 months. Data were collected using the CommCare application system and later analysed using Stata version 17. Vaccination coverage was estimated using a weighted analysis approach. A generalized estimating equation model was fitted to determine the predictors of zero-dose children. An adjusted odds ratio (AOR) with 95% confidence interval (CI) and a p-value of 0.05 or less was considered statistically significant.

resultsThe overall prevalence of zero-dose children in the study settings was 33.7% (95% CI: 34.9%, 75.7%). Developing and pastoralist regions, internally displaced peoples, newly formed regions, and conflict-affected areas had the highest prevalence of zero-dose children. Wealth index (poorest [AOR = 2.78; 95% CI: 1.70, 4.53], poorer [AOR = 1.96; 95% CI: 1.02, 3.77]), single marital status [AOR = 2.4; 95% CI: 1.7, 3.3], and maternal age (15-24 years) [AOR = 1.2; 95% CI: 1.1, 1.3] were identified as key determinant factors of zero-dose children in the study settings. Additional factors included fewer than four Antenatal care visits (ANC) [AOR = 1.3; 95% CI: 1.2, 1.4], not receiving Postnatal Care (PNC) services [AOR = 2.1; 95% CI: 1.5, 3.0], unavailability of health facilities within the village [AOR = 3.7; 95% CI: 2.6, 5.4], women-headed household [AOR = 1.3; 95% CI:1.02, 1.7], low gender empowerment [AOR = 1.6; 95% CI: 1.3, 2.1], and medium gender empowerment [AOR = 1.7; 95% CI: 1.2, 2.5].

conclusionIn the study settings, the prevalence of zero-dose children is very high. Poor economic status, disempowerment of women, being unmarried, young maternal age, and underutilizing antenatal or post-natal services are the important predictors. Therefore, it is recommended to target tailored integrated and context-specific service delivery approach. Moreover, extend immunization sessions opening hours during the evening/weekend in the city administrations to meet parents' needs.

Indexed as

MothersPrenatal CareChildCross-Sectional StudiesEthiopiaFemaleHumansPregnancyPrevalence12–35 months childrenDeveloping regionsGEE generalized estimating equationHard-to-reach underserved settingsPastoralistZero-dose coverage

Identifiers

PMID38395877
PMCPMC10893596
OpenAlexW4392099230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.